Standard Instruments

Standard BioTools, formerly known as Fluidigm, is a leading life science tools company focused on providing high-throughput analytical solutions for proteomics and genomics research. The company’s core technologies include mass cytometry (CyTOF) for high-parameter protein analysis and microfluidics-based systems for single-cell genomics and automated library preparation. Following its 2024 merger with SomaLogic, Standard BioTools has significantly expanded its capabilities in large-scale proteomics, offering the SomaScan platform for measuring thousands of proteins simultaneously. The company serves academic, pharmaceutical, and clinical research institutions globally, enabling breakthroughs in immunology, oncology, and precision medicine.